Role of APOC1 and NOP16 in the diagnosis of prostate cancer
APOC1 and NOP16 are anticipated to function as biomarkers for the early proactive diagnosis of PCa.
Authors
- Wei Zhuo (ORCID: https://orcid.org/0000-0002-8251-4210)
- Chang Hee Ye (ORCID: https://orcid.org/0009-0000-1757-3102)
- Ying Lu (ORCID: https://orcid.org/0000-0002-3545-1026)
- Zheqi Fan
- Yi Yan (ORCID: https://orcid.org/0000-0003-2860-3252)
- Songtao Shuang
- Bei Li (ORCID: https://orcid.org/0000-0002-6136-9894)
- Pan Lu (ORCID: https://orcid.org/0000-0002-2193-8415)
- Qin Yuan
Institutions
- Wuhan University of Technology (CN)
- The Central Hospital of Xiao gan (CN)
- Wuhan University of Science and Technology (CN)
Publication Details
- Journal
- BMC Urology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1186/s12894-025-02017-w
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00